Tag Archives: rapid titration risks

GLP-1 dose escalation is becoming a critical topic as demand for these therapies continues to surge. From semaglutide (Ozempic, Wegovy) to tirzepatide (Mounjaro), these medications are reshaping diabetes and weight management. However, are clinicians and patients moving faster than the evidence supports? As real-world practices evolve, dosing strategies often stray …

Read More »